Blood and fibroblast responses to thermoset BisGMA-TEGDMA/glass fiber-reinforced composite implants in vitro.

OBJECTIVES: This in vitro study was designed to evaluate both blood and human gingival fibroblast responses on fiber-reinforced composite (FRC) aimed to be used as oral implant abutment material. MATERIAL AND METHODS: Two different types of substrates were investigated: (a) Plain polymer (BisGMA 50%-TEGDMA 50%) and (b) FRC. The average surface roughness (Ra) was measured using spinning-disk confocal microscope. The phase composition was identified using X-ray diffraction analyzer. The degree of monomer conversion (DC%) was determined using FTIR spectrometry. The blood response, including the blood-clotting ability and platelet adhesion morphology, was evaluated. Fibroblast cell responses were studied in cell culture environment using routine test conditions. RESULTS: The Ra of the substrates investigated was less than 0.1 µm with no signs of surface crystallization. The DC% was 89.1 ± 0.5%. The FRC substrates had a shorter clotting time and higher platelets activation state than plain polymer substrates. The FRC substrates showed higher (P < 0.01-0.001) amount of adhered cells than plain polymer substrates at all time points investigated. The strength of attachment was evaluated using serial trypsinization, the number of cells detached from FRC substrates was 59 ± 5%, whereas those detached from the plane polymer substrates was 70 ± 5%, indicating a stronger (P < 0.01) cell attachment on the FRC surfaces. Fibroblasts grew more efficiently on FRC than on plain polymer substrates, showing significantly higher (P < 0.01) cell metabolic activities throughout the experiment. CONCLUSIONS: The presence of E-glass fibers enhances blood and fibroblast responses on composite surfaces in vitro.

In vitro blood and fibroblast responses to BisGMA-TEGDMA/bioactive glass composite implants.

This in vitro study was designed to evaluate both blood and human gingival fibroblast responses to bisphenol A-glycidyl methacrylate-triethyleneglycol dimethacrylate (BisGMA-TEGDMA)/bioactive glass (BAG) composite, aimed to be used as composite implant abutment surface modifier. Three different types of substrates were investigated: (a) plain polymer (BisGMA 50 wt%-TEGDMA 50 wt%), (b) BAG-composite (50 wt% polymer + 50 wt% fraction of BAG-particles, <50 µm), and (c) plain BAG plates (100 wt% BAG). The blood response, including the blood-clotting ability and platelet adhesion morphology were evaluated. Human gingival fibroblasts were plated and cultured on the experimental substrates for up to 10 days, then the cell proliferation rate was assessed using AlamarBlue assay™. The BAG-composite and plain BAG substrates had a shorter clotting time than plain polymer substrates. Platelet activation and aggregation were most extensive, qualitatively, on BAG-composite. Analysis of the normalized cell proliferation rate on the different surfaces showed some variations throughout the experiment, however, by day 10 the BAG-composite substrate showed the highest (P < 0.001) cell proliferation rate. In conclusion, the presence of exposed BAG-particles enhances fibroblast and blood responses on composite surfaces in vitro.

Osteoblast proliferation and maturation on bioactive fiber-reinforced composite surface.

The objective of this study was to evaluate the proliferation and osteogenic potential of bone-marrow derived osteoblast-like cells on fiber-reinforced composite (FRC) substrates with and without bioactive glass surface modification. Three FRC materials were fabricated for the study: (a) grit-blasted FRC, (b) grit-blasted FRC with bidirectional net reinforcement and (c) FRC with bioactive glass (BAG) coating. Rat bone-marrow derived osteoblast-like cells were harvested and cultured on experimental material plates and on cp. titanium plates (control) for 21 days. The materials' surfaces were characterized by roughness testing and scanning electron microscopy. Cell growth and differentiation kinetics were subsequently investigated by evaluating proliferation, alkaline phosphatase (ALP) activity, osteocalcin (OC) and bone sialoprotein (BSP) production. On day 14, the cell proliferation was significantly lower (P<0.05) on FRC-BAG than on titanium and FRC. The proliferation on the other three materials was equal throughout the experiment. The maximal ALP activities on FRC, FRC-Net, and titanium were observed on day 21, whereas FRC-BAG had already reached the maximal level on day 14. Expression of osteoblastic markers (OC, BSP) indicates that the fastest osteogenic differentiation takes place on FRC after 7 days. In contrast, a slower differentiation process was observed on titanium than on any other tested material (P<0.015) at 21 days, as was confirmed by increased mRNA expression of OC and BSP. It can be concluded that the proliferation and maturation of osteoblast-like cells on FRC appears to be comparable to titanium. Presence of BAG enhances cell maturation.

Mechanical properties of oligomer-modified acrylic bone cement.

The aim of this study was to determine the mechanical properties of acrylic bone cement modified with an experimental oligomer filler, based on an amino acid of trans-4-hydroxy-L-proline synthesized in the laboratory. The test specimens were tested either dry, or after being stored in distilled water or in simulated body fluid (SBF) for 1 week and then tested in distilled water. The three-point bending test was used to measure the flexural strength and flexural modulus of the cement, and the compression tests were used to measure the compression strength and modulus. One test specimen from each group was examined under a scanning electron microscope (SEM) to determine the nature of the oligomer filler in the polymethylmethacrylate-polymethylacrylate copolymer-based (PMMA-PMA/PMMA) polymer blend. In dry conditions, the flexural strength of the test specimens tested in air was 66 MPa, and the compression strength was 93 GPa (p<0.001) for the plain bone cement. For the test specimens including 20 wt% of oligomer filler, the flexural strength was 37 MPa, and the compression strength was 102 MPa(p<0.001) in dry conditions. The storage in wet conditions (in distilled water and the SBF) decreased the flexural strength of the test specimens with 20 wt% of oligomer filler (p<0.001) by 60% and the flexural modulus by 44% compared to the plain bone cement specimens stored in the same conditions. The reduction in compression strength in wet conditions was 32%, and that of the compression modulus was 30% (p<0.001). No significant differences were found between test specimens stored in distilled water or SBF (ANOVA, p<0.001). In the SEM examinations, random voids were observed in the oligomer-PMMA-PMA/PMMA polymer blend after water or SBF storage. The results suggest that both water and SBF storage decrease the mechanical properties of the PMMA-PMA/PMMA bone cement modified with oligomer, while at the same time, there was porous formation in the bone cement structure.